Tavalisse

RxNorm concept 2044923, brand name (bn).

RxCUI: 2044923
Term type: Brand name (BN)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/2044923 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

fostamatinib 2044896

Related concepts

fostamatinib 100 MG [Tavalisse] (SBDC, ingredient of)
fostamatinib Oral Tablet [Tavalisse] (SBDF, ingredient of)
Tavalisse Oral Product (SBDG, ingredient of)
Tavalisse Pill (SBDG, ingredient of)
fostamatinib 100 MG Oral Tablet [Tavalisse] (SBD, ingredient of)
fostamatinib 150 MG [Tavalisse] (SBDC, ingredient of)
fostamatinib 150 MG Oral Tablet [Tavalisse] (SBD, ingredient of)
fostamatinib (IN, tradename of)

Linked data

NDCs

RxNorm links no NDCs to this concept.

Use it

Look up 2044923 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/2044923 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 2044923. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.